Year |
Citation |
Score |
2018 |
Layek B, Sadhukha T, Panyam J, Prabha S. Nano-engineered mesenchymal stem cells increase therapeutic efficacy of anticancer drug through true active tumor targeting. Molecular Cancer Therapeutics. PMID 29592881 DOI: 10.1158/1535-7163.Mct-17-0682 |
0.527 |
|
2017 |
Sadhukha T, Layek B, Prabha S. Incorporation of lipolysis in monolayer permeability studies of lipid-based oral drug delivery systems. Drug Delivery and Translational Research. PMID 28462499 DOI: 10.1007/S13346-017-0383-6 |
0.342 |
|
2017 |
Kirtane AR, Sadhukha T, Kim H, Khanna V, Koniar B, Panyam J. Fibrinolytic enzyme co-therapy improves tumor perfusion and therapeutic efficacy of anticancer nanomedicine. Cancer Research. PMID 28108516 DOI: 10.1158/0008-5472.Can-16-1646 |
0.447 |
|
2017 |
Sehgal D, Kalscheuer S, Sadhukha T, Panyam J. Abstract 4593: Glycoengineered antibodies for click chemistry applications Cancer Research. 77: 4593-4593. DOI: 10.1158/1538-7445.Am2017-4593 |
0.334 |
|
2016 |
Layek B, Sadhukha T, Prabha S. Glycoengineered mesenchymal stem cells as an enabling platform for two-step targeting of solid tumors. Biomaterials. 88: 97-109. PMID 26946263 DOI: 10.1016/J.Biomaterials.2016.02.024 |
0.493 |
|
2015 |
Fernández-Gallardo J, Elie BT, Sadhukha T, Prabha S, Sanaú M, Rotenberg SA, Ramos JW, Contel M. Heterometallic titanium-gold complexes inhibit renal cancer cells in vitro and in vivo. Chemical Science (Royal Society of Chemistry : 2010). 6: 5269-5283. PMID 27213034 DOI: 10.1039/C5Sc01753J |
0.323 |
|
2014 |
Sadhukha T, O'Brien TD, Prabha S. Nano-engineered mesenchymal stem cells as targeted therapeutic carriers. Journal of Controlled Release : Official Journal of the Controlled Release Society. 196: 243-51. PMID 25456830 DOI: 10.1016/J.Jconrel.2014.10.015 |
0.536 |
|
2014 |
Frik M, MartÃnez A, Elie BT, Gonzalo O, RamÃrez de Mingo D, Sanaú M, Sánchez-Delgado R, Sadhukha T, Prabha S, Ramos JW, Marzo I, Contel M. In vitro and in vivo evaluation of water-soluble iminophosphorane ruthenium(II) compounds. A potential chemotherapeutic agent for triple negative breast cancer. Journal of Medicinal Chemistry. 57: 9995-10012. PMID 25409416 DOI: 10.1021/Jm5012337 |
0.345 |
|
2014 |
Sadhukha T, Wiedmann TS, Panyam J. Enhancing therapeutic efficacy through designed aggregation of nanoparticles. Biomaterials. 35: 7860-9. PMID 24947232 DOI: 10.1016/J.Biomaterials.2014.05.085 |
0.561 |
|
2014 |
Sadhukha T, Prabha S. Encapsulation in nanoparticles improves anti-cancer efficacy of carboplatin. Aaps Pharmscitech. 15: 1029-38. PMID 24831091 DOI: 10.1208/S12249-014-0139-2 |
0.525 |
|
2014 |
Prabha S, Sadhukha T. Abstract 5420: Nano-engineered mesenchymal stem cells as targeted therapeutic carriers Cancer Research. 74: 5420-5420. DOI: 10.1158/1538-7445.Am2014-5420 |
0.575 |
|
2013 |
Sadhukha T, Wiedmann TS, Panyam J. Inhalable magnetic nanoparticles for targeted hyperthermia in lung cancer therapy. Biomaterials. 34: 5163-71. PMID 23591395 DOI: 10.1016/J.Biomaterials.2013.03.061 |
0.636 |
|
2013 |
Sadhukha T, Niu L, Wiedmann TS, Panyam J. Effective elimination of cancer stem cells by magnetic hyperthermia. Molecular Pharmaceutics. 10: 1432-41. PMID 23432410 DOI: 10.1021/Mp400015B |
0.599 |
|
2012 |
Wiedmann TS, Sadhukha T, Hammer BE, Panyam J. Image-guided drug delivery in lung cancer. Drug Delivery and Translational Research. 2: 31-44. PMID 25786598 DOI: 10.1007/S13346-011-0053-Z |
0.567 |
|
2010 |
Patil YB, Swaminathan SK, Sadhukha T, Ma L, Panyam J. The use of nanoparticle-mediated targeted gene silencing and drug delivery to overcome tumor drug resistance. Biomaterials. 31: 358-65. PMID 19800114 DOI: 10.1016/J.Biomaterials.2009.09.048 |
0.494 |
|
2009 |
Grill AE, Johnston NW, Sadhukha T, Panyam J. A review of select recent patents on novel nanocarriers. Recent Patents On Drug Delivery & Formulation. 3: 137-42. PMID 19519573 DOI: 10.2174/187221109788452276 |
0.347 |
|
2009 |
Patil Y, Sadhukha T, Ma L, Panyam J. Nanoparticle-mediated simultaneous and targeted delivery of paclitaxel and tariquidar overcomes tumor drug resistance. Journal of Controlled Release : Official Journal of the Controlled Release Society. 136: 21-9. PMID 19331851 DOI: 10.1016/J.Jconrel.2009.01.021 |
0.516 |
|
Show low-probability matches. |